Articles
Today, Histogen CEO Richard Pascoe presented at the BIO Investor Forum in San Francisco, CA. During his BIO presentation, Richard Pascoe discussed Histogen’s current therapeutic programs including dermal fillers, cartilage repair, and of course, hair growth. Pascoe shared that the company is planning to conduct a dose-ranging study for their lead product, HSC, in the…
Read More
In this article we will take a look at the technical side of the hair cloning startup from Manchester, UK. Much has been discussed about HairClone over the past couple of years. The company has amassed a global network of hair transplant surgeons that have signed on to become clinical partners. The likes of Dr.…
Read More
One of the leading researchers in the field of mitochondrial science has started a company to reverse the effects of human aging, including hair loss. In July 2018, researchers at the University of Alabama, led by Keshav Singh PhD, published findings on a novel model for restoring mitochondrial function. The team found that by turning…
Read More
Follicle Thought was recently featured in a publication for InStyle Magazine. The article, which is titled Men’s Hair Loss is a Multi-Billion Dollar Industry (and Growing), focuses on current trends in the hair loss industry and the stigma behind losing one’s hair. New direct-to-consumer companies such as Hims and Keeps are featured in the write-up,…
Read MoreSwedish company Follicum has announced new information regarding their clinical trial schedule and product development. The last completed milestone we had heard from Follicum was results from their phase 2a clinical trial of FOL-005. During that trial which completed in late 2018, the peptide FOL-005 was injected into the scalps of 60 participants three times…
Read More
One of the most popular hair-growth research discoveries in recent years is finally making its way into clinical trials. If successful, a product could become available sooner than expected. In May 2018, an article published in the PLOS journal by Hawkshaw et al., showed that SFRP1 inhibition was a novel way of promoting human hair…
Read More
Update 3/20/20 New HairCell Results Posted Last week, the HairCell company shared more photo results from their pilot trial which is ongoing in South Africa. There are now 6 new before and after comparisons on the HairCell website. Below, I’ve shared one of the best results from the new data posted. Subject “Jason” appears to…
Read More
In this article, Follicle Thought talks “all things hair science” with one of the most prolific hair biology researchers in the field, Dr. Ralf Paus. A recent publication from The Guardian featuring several of the latest technologies being developed to treat hair loss included some interesting remarks from Dr. Paus. Coincidentally, I had conducted a…
Read More
SM04554, a Wnt activator from Samumed, is currently the only new drug worldwide at a phase 3 trial for androgenic alopecia. Last month, Samumed’s CEO Osman Kibar was featured in a Fierce Biotech article which covered Samumed’s various programs for oncology, arthritis, and of course – alopecia. At the end of the article there was…
Read MoreJ. Hewitt, a regenerative medicine company from Japan, has told Follicle Thought they plan to start a pivotal hair multiplication clinical trial in Japan by the end of the year. J.Hewitt & TissUse SHT Collaboration In early 2019, TissUse issued a press release announcing it had granted J. Hewitt of Japan the first license to…
Read More